Efficiency of colorectal cancer surveillance in patients with ulcerative colitis: 26 years’ experience in a patient cohort from a defined population area

References

• Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526–35
   PubMed Web of Science ®Google Scholar
• Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988; 29: 206–17
   PubMed Web of Science ®Google Scholar
• Bruewer M, Kriegelstein CF, Utech M, Bode M, Rijcken E, Anthori L, et al. Is colonoscopy alone sufficient to screen for ulcerative colitis-associated colorectal carcinoma?. World J Surg 2003; 27: 611–5
   PubMedGoogle Scholar
• Ullman TA, Loftus EV, Jr, Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 2002; 97: 922–7
   PubMed Web of Science ®Google Scholar
• Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Granqvist S. Twenty years’ colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand J Gastroenterol 1996; 31: 1195–204
   PubMed Web of Science ®Google Scholar
• Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934–44
   PubMed Web of Science ®Google Scholar
• Lindberg JO, Stenling RB, Rutegard JN. DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis. Br J Surg 1999; 86: 947–50
   PubMedGoogle Scholar
• Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis: a 15-year follow-up study. Gastroenterology 1990; 99: 1021–31
   PubMed Web of Science ®Google Scholar
• Holzmann K, Weis-Klemm M, Klump B, Hsieh CJ, Borchard F, Gregor M, et al. Comparison of flow cytometry and histology with mutational screening for p53 and Ki-ras mutations in surveillance of patients with long-standing ulcerative colitis. Scand J Gastroenterol 2001; 36: 1320–6
   PubMedGoogle Scholar
• Sjoqvist U, Ost A, Lofberg R. Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis. Int J Colorectal Dis 1999; 14: 107–13
   PubMedGoogle Scholar
• Pohl C, Hombach A, Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 2000; 47: 57–70
   PubMedGoogle Scholar
• Collins RH, Jr, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987; 316: 1654–8
   PubMed Web of Science ®Google Scholar
• Lynch DA, Lobo AJ, Sobala GM, Dixon MF, Axon AT. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993; 34: 1075–80
   PubMed Web of Science ®Google Scholar
• Rutegard J, Ahsgren L, Stenling R, Janunger KG. Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol 1988; 23: 139–45
   PubMed Web of Science ®Google Scholar
• Jonsson B, Ahsgren L, Andersson LO, Stenling R, Rutegard J. Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg 1994; 81: 689–91
   PubMedGoogle Scholar
• Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Feneglio CM, Haggit RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931–68
   PubMed Web of Science ®Google Scholar
• Lindberg JO, Stenling RB, Rutegard JN. Eighteen-year surveillance of dysplasia-associated lesion in ulcerative colitis. Endoscopy 2000; 32: 359–60
   PubMedGoogle Scholar
• Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology 1992; 103: 431–8
   PubMed Web of Science ®Google Scholar
• Okayasu I, Yamada M, Mikami T, Yoshida T, Kanno J, Ohkusa T. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J Gastroenterol Hepatol 2002; 17: 1078–83
   PubMedGoogle Scholar
• Biasco G, Rossini FP, Hakim R, Bianchi G, Di Battista M, Di Febo G, et al. Cancer surveillance in ulcerative colitis: critical analysis of a long-term prospective programme. Dig Liver Dis 2002; 34: 339–42
   PubMedGoogle Scholar
• Rhodes JM. Surveillance for colitis-associated cancer: we cannot stop now. Dig Liver Dis 2002; 34: 319–21
   PubMedGoogle Scholar
• Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998; 42: 711–4
   PubMed Web of Science ®Google Scholar